Gynecologists Discover Treatment for Chemotherapy-Resistant Ovarian Cancer
August 1, 2003
Phenoxodiol is a drug of a new kind that interferes with the mechanisms that allow ovarian cancer cells to stay alive. The drug drastically reduces the concentration of chemotherapy drug needed to kill the cell. Doctors say Phenoxodiol has a 20 to 30 percent success rate on cancers that would not otherwise respond to chemotherapy or other treatments.
